Inflammatory breast carcinoma: results from sixteen patients treated with chemo-radiotherapy and surgery.
Chemioterapia
; 3(2): 86-9, 1984 Apr.
Article
em En
| MEDLINE
| ID: mdl-6532541
ABSTRACT
Inflammatory breast carcinoma is a dramatic tumour with a five-year survival rate of almost 3%. Various therapeutic approaches have been made for this neoplasia surgery, radiotherapy and chemotherapy, alone or in combination. The best results were obtained with the use of a multidisciplinary approach. The authors developed a treatment in which chemotherapy and radiotherapy, together with surgery, are used. After three cycles of CMF (cyclophosphamide, methotrexate, 5-fluorouracil) the patients with partial remission, no change or disease progression were changed to adriamycin + vincristine plus radiotherapy. Surgery was performed on patients with complete remission or partial remission after chemo-radiotherapy. After surgery, maintenance chemotherapy was used with the more active drugs. The actuarial survival rate at 5 years was 30.65% and median survival 34 months.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Carcinoma
Limite:
Female
/
Humans
Idioma:
En
Revista:
Chemioterapia
Ano de publicação:
1984
Tipo de documento:
Article